INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of Federal Securities Laws by the Board of Zosano Pharma Corporation -- ZSAN
PR Newswire

NEW YORK, Feb. 9, 2016 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of Zosano Pharma Corporation (NASDAQCM: ZSAN) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. 

Levi & Korsinsky, LLP

The investigation concerns whether the Company's filings with the SEC in connection with its January 2015 Initial Public Offering contained untrue statements or omitted material information. Zosano offered more than 6,500,000 shares of its common stock at $11.00 per share in connection with its IPO. A year later, Zosano Pharma stock has plummeted to close at just $2.02 on January 19, 2016. To obtain additional information, go to: or contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (866) 367-6510

Logo -

To view the original version on PR Newswire, visit:

SOURCE Levi & Korsinsky, LLP

 Top of page